Jordan F. Karp: Clinical Trials

2 trials sponsored by Jordan F. Karp, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Withdrawn 1

Follow Jordan F. Karp: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Deep Brain Stimulation to Relieve Depression
Medtronic Activa SC DBS, Lead Model 3387 - Treatment Resistant Depression
Phase 3WithdrawnJordan F. Karp2018-06-012018-08-06
Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
Buprenorphine, Placebo - Depression, Major Depressive Disorder
Phase 2CompletedJordan F. Karp312014-08-012018-08-29

Conditions studied

Depression (2)  ·  Depressive Disorder, Major (1)  ·  Depressive Disorder, Treatment-Resistant (1)

Interventions

Buprenorphine (1)  ·  Buprenorphine, Naloxone Drug Combination (1)

Countries

United States (1)

Top investigators

Jordan F. Karp, M.D. (1)

NIH funding

R34MH101371 (1)